Strengthening Cost-Effectiveness Analysis for Public Health Policy

American Journal of Preventive Medicine

Volumn 50, Issue 5, 2016, Pages S6-S12

  Russell, Louise B ^a,c   Sinha, Anushua ^b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^c RUTGERS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; HUMAN; PUBLIC HEALTH; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH CARE POLICY; QUALITY ADJUSTED LIFE YEAR;

COST-BENEFIT ANALYSIS; HEALTH POLICY; HUMANS; PUBLIC HEALTH; QUALITY-ADJUSTED LIFE YEARS;

EID: 84963865523     PISSN: 07493797     EISSN: 18732607     Source Type: Journal    
DOI: 10.1016/j.amepre.2015.11.007     Document Type: Article

References (36)

1. NHE Summary, including share of GDP, CY 1960-2013, Table 1. http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/nationalHealthAccountsHistorical.html. Accessed July 9, 2015.
2. S.H. Woolf, L. Aron Panel on Understanding Cross-National Health Differences Among High-Income Countries; Committee on Population; Division of Behavioral and Social Sciences and Education; National Research Council; Board on Population Health and Public Health Practice; Institute of Medicine U.S. Health in International Perspective: Shorter Lives, Poorer Health 2013 The National Academies Press Washington, DC
3. S. Teutsch, and J.E. Fielding Rediscovering the core of public health Front Public Health Serv Syst Res 2 3 2013 1 7 Article 1
4. IOM, National Academy of Sciences, Engineering, Medicine. Topic: environmental health. http://iom.nationalacademies.org/Global/Topics/Environmental-Health.aspx. Accessed July 15, 2015.
5. M.R. Gold, J.E. Siegel, L.B. Russell, and M.C. Weinstein Cost-Effectiveness in Health and Medicine 1996 Oxford University Press New York, NY
6. L.B. Russell The science of making better decisions about health: cost-effectiveness and cost-benefit analysis R.M. Kaplan, D. David, M. Spittel, Emerging Behavioral and Social Science Perspectives on Population Health 2015 U.S. Government Printing Office Washington, DC
7. L.B. Russell Is Prevention Better than Cure? 1986 The Brookings Institution Washington, DC
8. J.T. Cohen, P.J. Neumann, and M.C. Weinstein Does preventive care save money? Health economics and the presidential candidates N Engl J Med 358 7 2008 661 663 10.1056/NEJMp0708558
9. L.B. Russell Preventing chronic disease: an important investment, but don't count on cost savings Health Aff (Millwood) 28 1 2009 42 45 10.1377/hlthaff.28.1.42
10. J. Cromwell, W.J. Bartosch, M.C. Fiore, and et al. Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation JAMA 278 21 1997 1759 1766 10.1001/jama.1997.03550210057039
11. J. Mandelblatt, S. Saha, S. Teutsch, and et al. The cost-effectiveness of screening mammography beyond age 65 years: a systematic review for the U.S. Preventive Services Task Force Ann Intern Med 139 10 2003 835 842 10.7326/0003-4819-139-10-200311180-00011
12. National Cancer Institute. Cancer Intervention and Surveillance Modeling Network: Modeling to guide public health research and priorities. http://cisnet.cancer.gov/about/. Accessed March 10, 2015.
13. J.J. Caro, A.H. Briggs, U. Siebert, and K.M. Kuntz Modeling Good Research Practices - Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1 Med Decis Making 32 5 2012 667 677 10.1177/0272989X12454577
14. PRISMA (Transparent Reporting of Systematic Reviews and Meta-Analyses). www.prisma-statement.org/. Accessed July 7, 2015.
15. Cochrane Community Reviews. www.cochrane.org/cochrane-reviews. Accessed July 7, 2015.
16. IOM. Finding What Works in Health Care: Standards for Systematic Reviews. www.iom.edu/Reports/2011/Finding-What-Works-in-Health-Care-Standards-for-systematic-Reviews.aspx. Published 2011. Accessed July 7, 2015.
17. National Institute for Health and Care Excellence (NICE). Guide to the methods of technology appraisal. Published 2013. http://publications.nice.org.uk/pmg9. April 4, 2013.
18. Canadian Agency for Drugs and Technologies in Health (CADTH) Guidelines for the economic evaluation of health technologies: Canada 3rd ed. 2006 Canadian Agency for Drugs and Technologies in Health Ottawa
19. Australian Government, Department of Health and Ageing, Pharmaceutical Benefits Advisory Commission (PBAC). Guidelines for Preparing Submissions to the Pharmaceutical Benefits Advisory Committee (Version 4.3). http://www.pbac.pbs.gov.au/content/information/archived-versions/pbac-guidelines-v4.3-2008.pdf. Published December 2008. Accessed November 19, 2015.
20. WHO. WHO guide to cost-effectiveness analysis. Published 2003. www.who.int/choice/publications/p-2003-generalised-cea.pdf.
21. Bill and Melinda Gates Foundation. Methods for Economic Evaluation Project (MEEP) Final Report. A partnership between Bill and Melinda Gates Foundation, NICE International, the Health Intervention and Technology Assessment Program (Thailand), and the University of York, Centre for Health Economics. https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-International/projects/MEEP-report.pdf. January 2014. Accessed November 19, 2015.
22. J.A. Salomon, T. Vos, D.R. Hogan, and et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010 Lancet 380 9859 2012 2129 2143 http://dx.doi.org/10.1016/S0140-6736(12)61680-8
23. A.E. Boardman, D.H. Greenberg, A.R. Vining, and D.L. Weimer Cost-Benefit Analysis: Concept and Practice 2011 Prentice Hall New York NY
24. A.M. Freeman III The Measurement of Environmental and Resource Values: Theory and Methods Second Edition 2003 Resources for the Future Washington, DC
25. IOM An Integrated Framework for Assessing the Value of Community-Based Prevention 2012 The National Academies Press Washington, DC
26. Social Value Judgements: Principles for the Development of NICE Guidance. Second Edition. National Institute for Health and Clinical Excellence website. http://www.nice.org.uk/proxy/?sourceUrl=http%3a%2f%2fwww.nice.org.uk%2fmedia%2fC18%2f30%2fSVJ2PUBLICATION2008.pdf. Published 2008. Accessed November 19, 2015.
27. U.S. Environmental Protection Agency, Office of Air and Radiation The Benefits and Costs of the Clean Air Act from 1990 to 2020: Summary Report March 2011 U.S. Environmental Protection Agency Washington, DC
28. Stone GA, Hutchinson AB, Corso PS, et al. Chapter 11: understanding and using the economic evidence. In: The Guide to Community Preventive Services: What Works to Promote Health? www.thecommunityguide.org/library/economics.pdf. Accessed June 8, 2015.
29. M.W. Jone-Lee The Value of Life: An Economic Analysis 1976 The University of Chicago Press Chicago, IL
30. M.W. Jones-Lee, M. Hammerton, and P.R. Philips The value of safety: results of a national sample survey Econ J 95 377 1985 49 72 10.2307/2233468
31. A.L. Nichols Lead in gasoline R.D. Morgenstern, Economic Analyses at EPA: Assessing Regulatory Impact 1997 Resources for the Future Washington, DC 49 86
32. U.S. Office of Management and Budget, Circular A-4, Subject: Regulatory Analysis, September 17, 2003. www.whitehouse.gov/omb/circulars-a004-a-4/. Accessed July 14, 2015.
33. L.A. Robinson How US government agencies value mortality risk reductions Rev Environ Econ Policy 1 2 2007 283 299 10.1093/reep/rem018
34. L.B. Russell Do we really value identified lives more highly than statistical lives? Med Decis Making 34 5 2014 556 559 10.1177/0272989X13512183
35. L.B. Russell Completing costs: patients' time Med Care 47 7 Suppl 1 2009 S89 S93 http://dx.doi.org/10.1097/MLR.0b013e31819bc077
36. W. Miller, L.A. Robinson, R.S. Lawrence Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation, eds. Valuing Health for Regulatory Cost-Effectiveness Analysis 2006 The National Academies Press Washington, DC